How should dermatologists evaluate whether lebrikizumab is a better option than dupilumab for a given patient?
Featuring Pearl Kwong, MD | HCA Florida Orange Park HospitalJacksonville, Florida | Published July 01, 2025
Related Media
Powered by Polaris TM